MedPath
NMPA Approval

Olmesartan Medoxomil Tablets

国药准字H20233832

January 19, 2024

Drug Information

奥美沙坦酯片

片剂

20mg

化学药品

January 19, 2024

Company Information

Applicant Company

重庆市渝中区长江二路12号第三层

Manufacturing Company

重庆市南岸经济技术开发区大石支路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯片 - NMPA 批准文号 | MedPath